Stryker Corp
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.
Trading 38% above its estimated fair value of $206.96.
Current Price
$331.54
+0.65%GoodMoat Value
$206.96
37.6% overvaluedStryker Corp (SYK) Historical Performance
Stryker Corp — Historical Performance
SYK · NYSE · Healthcare
GoodMoat Target
“When a medical device maker trades at nearly 40 times earnings, you're paying champagne prices for what might just be good beer.”
— In the voice of Buffett
What is the Historical Performance?
Interactive price chart with 10+ years of historical data. Identify trends, support levels, and long-term performance patterns.
Key Metrics
Market Cap
$126.79B
P/E Ratio
39.06
Forward P/E
—
EPS
$8.40
PEG Ratio
0.72
Book Value
$58.63
Dividend Yield
1.01%
Profit Margin
12.92%
ROE
14.48%
Historical Performance — Data
Pre-loaded data for SYK:
Stryker Corp (SYK) Historical Performance
Interactive price chart with 10+ years of historical data. Identify trends, support levels, and long-term performance patterns.
Stryker Corp is a Healthcare company in the Medical Devices industry, listed on NYSE. Current stock price: $331.54. Market capitalization: $126.79B. EPS: $8.40. P/E ratio: 39.06.
GoodMoat Fair Value target: $206.96. The stock appears 60.2% overvalued based on our blended model.
Use GoodMoat's Historical Performance alongside other valuation tools including DCF Calculator, Reverse DCF, Fair Value models, and Quality Score to build a comprehensive investment thesis for Stryker Corp (SYK). All tools are free to use and powered by real-time financial data.